Inflammation of BCG Inoculation Site Scar after the First Dose of an Anti-SARS-CoV-2 mRNA Vaccine

João Barros Rodrigues; Maria Pacheco; Ivan Antunes; Ricardo Sousa

doi:10.20344/amp.16971

Inflammation of BCG Inoculation Site Scar after the First Dose of an Anti-SARS-CoV-2 mRNA Vaccine

Authors

João Barros Rodrigues Serviço de Medicina Interna. Unidade Local de Saúde da Guarda. Guarda.
Maria Pacheco Serviço de Medicina Interna. Unidade Local de Saúde da Guarda. Guarda.
Ivan Antunes Serviço de Medicina Interna. Unidade Local de Saúde da Guarda. Guarda.
Ricardo Sousa Serviço de Medicina Geral e Familiar. Unidade de Saúde Familiar de Terras do Souza. Paredes.

DOI:

https://doi.org/10.20344/amp.16971

Keywords:

BCG Vaccine, Cicatrix, COVID-19 Vaccines, Drug-Related Side Effects and Adverse Reactions, mRNA Vaccines, SARS-CoV-2

Abstract

Inflammatory reactions in the Bacillus Calmette-Guérin (BCG) inoculation scar site have been previously described, in association with viral infections. The inflammation of the scar in association with other vaccines has been described with the flu vaccine and, more recently, after the second dose of mRNA anti-SARS-CoV-2 vaccines (mRNA-1273 e BNT162b2), in two healthcare workers. We present the case of a 27-year-old female, without a relevant past medical history, including no previous SARS-CoV-2 infection, and with inflammation of the BCG scar eight days after the first dose of the mRNA anti-SARS-CoV-2 vaccine. Pharmacovigilance and the notification of adverse events should be encouraged, as a way of warding off hesitation in this process.

Downloads

Download data is not yet available.

Downloads

PDF (Português)

Published

2022-09-19

How to Cite

Barros Rodrigues J, Pacheco M, Antunes I, Sousa R. Inflammation of BCG Inoculation Site Scar after the First Dose of an Anti-SARS-CoV-2 mRNA Vaccine. Acta Med Port [Internet]. 2022 Sep. 19 [cited 2023 Feb. 9];. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/16971

Download Citation

Issue

In Press

Section

Case Report

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.